2021 Virtual American Diabetes Association 81st Scientific Session

Share on: 
June 25 to June 29, 2021

Research co-authored by RTI Health Solutions researchers will be presented at the 2021 Virtual American Diabetes Association 81st Scientific Session.

Risk of acute kidney injury in real-world use of dapagliflozin. Johannes C, Layton JB, Beachier D, Ziemiecki R, Li L, Danysh H, Dinh J, Hunt P, Karlsson C, Chen H, Gilsenan A. Presentation 

Risk of acute liver injury in real-world use of dapagliflozin. Johannes C, Layton JB, Beachler D, Ziemiecki R, Li L, Danysh H, Dinh J, Hunt P, Karlsson C, Chen H, Gilsenan A. Poster 

Risk of severe complications of urinary tract infection in real-world use of dapagliflozin. Johannes C, Layton JB, Beachler D, Ziemiecki R, Li L, Danysh H, Dinh J, Hunt P, Karlsson C, Chen H, Gilsenan A. Poster 

Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the US. Mody R, Meyers J, Yu M, Levine J, Davis KL. Poster 

Related Services:
Conference participants: